Bausch Health Companies (BHC) Dividend Coverage Ratio (2009 - 2014)
Bausch Health Companies' (BHC) quarterly Dividend Coverage Ratio came in at 6.85 in Q1 2014, up 99.99% quarter-over-quarter from 123800.0 in Q4 2013.
Analysis
Bausch Health Companies (BHC) Dividend Coverage Ratio (2009 - 2014) Analysis & Trends
Bausch Health Companies has disclosed Dividend Coverage Ratio across 6 years of filings, most recently posting 6.85 for Q1 2014.
- In Q1 2014, Dividend Coverage Ratio changed N/A year-over-year to 6.85; the TTM figure through Jun 2014 stood at 138.19 (down 462.86% YoY), while the FY2017 annual figure was 133.56, up 149.9% from the prior year.
- Dividend Coverage Ratio came in at 6.85 for Q1 2014 at Bausch Health Companies, up from 123800.0 in the prior quarter.
- In the past five years, Dividend Coverage Ratio ranged from a high of 2.38 in Q2 2010 to a low of 123800.0 in Q4 2013.
- Average Dividend Coverage Ratio over 5 years is 12430.46, with a median of 4.4 recorded in 2011.
- Year-over-year, Dividend Coverage Ratio jumped 486.85% in 2010 and tumbled 555574.0% in 2013.
- Over 5 years, Dividend Coverage Ratio stood at 0.1 in 2010, then slumped by 1867.76% to 1.96 in 2011, then slumped by 1037.4% to 22.28 in 2012, then plunged by 555574.0% to 123800.0 in 2013, then jumped by 99.99% to 6.85 in 2014.
- Per Business Quant data, the three most recent Dividend Coverage Ratio figures were 6.85 in Q1 2014, 123800.0 in Q4 2013, and 463.21 in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -0.85 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | -6.85 |
| Dec 31, 2013 | -123,800.00 |
| Sep 30, 2013 | -463.21 |
| Dec 31, 2012 | -22.28 |
| Dec 31, 2011 | -1.96 |
| Sep 30, 2011 | 1.43 |
| Dec 31, 2010 | -0.10 |
| Sep 30, 2010 | -13.80 |
| Jun 30, 2010 | 2.38 |
| Mar 31, 2010 | -0.22 |
| Dec 31, 2009 | 1.04 |
| Sep 30, 2009 | 2.83 |
| Jun 30, 2009 | 0.41 |